Remifentanil and other opioids

60Citations
Citations of this article
37Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Most opioids used in anaesthesia are of the anilidopiperidine family, including fentanyl, alfentanil, sufentanil and remifentanil. While all share similar pharmacological properties, remifentanil, the newest one, is probably the most original, which is the reason this review focusses especially on this drug. Remifentanil is a potent μ-agonist that retains all the pharmacodynamic characteristics of its class (regarding analgesia, respiratory depression, muscle rigidity, nausea and vomiting, pruritus, etc.) but with a unique pharmacokinetic profile that combines a short onset and the fastest offset, independent of the infusion duration. Consequently, it offers a unique titratability when its effects need to be quickly achieved or suppressed, but it requires specific drug delivery schemes such as continuous infusion, target-controlled infusion and anticipated postoperative pain treatment. Kinetic differences between opioids used in anaesthesia and some clinical uses of remifentanil are reviewed in this chapter. © 2008 Springer-Verlag Berlin Heidelberg.

Cite

CITATION STYLE

APA

Servin, F. S., & Billard, V. (2008). Remifentanil and other opioids. Handbook of Experimental Pharmacology, 182, 283–311. https://doi.org/10.1007/978-3-540-74806-9_14

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free